![](https://webarchive.library.unt.edu/eot2008/20081005104919im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 4: April 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20081005104919im_/http://www.fda.gov/cder/graphics/pdf.gif)
ALENDRONATE SODIUM; CHOLECALCIFEROL
TABLET; ORAL
FOSAMAX PLUS D
>D> + MERCK EQ 70MG BASE;2,800 IU N21762 001 Apr 07, 2005 Apr CRLD
>A> EQ 70MG BASE;2,800 IU N21762 001 Apr 07, 2005 Apr CRLD
>A> + EQ 70MG BASE;5,600 IU N21762 002 Apr 26, 2007 Apr NEWA
ALPROSTADIL
INJECTABLE; INJECTION
>D> CAVERJECT
>D> PHARMACIA AND 0.01MG/VIAL N21212 001 Jun 11, 2002 Apr CTNA
>D> 0.02MG/VIAL N21212 002 Jun 11, 2002 Apr CTNA
>A> CAVERJECT IMPULSE
>A> PHARMACIA AND 0.01MG/VIAL N21212 001 Jun 11, 2002 Apr CTNA
>A> 0.02MG/VIAL N21212 002 Jun 11, 2002 Apr CTNA
ARIPIPRAZOLE
SOLUTION; ORAL
ABILIFY
>D> + OTSUKA 1MG/ML N21713 001 Dec 10, 2004 Apr CAHN
>A> + OTSUKA PHARM 1MG/ML N21713 001 Dec 10, 2004 Apr CAHN
AZITHROMYCIN
>A> SOLUTION/DROPS; OPHTHALMIC
>A> AZASITE
>A> + INSITE VISION 1% N50810 001 Apr 27, 2007 Apr NEWA
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL; TOPICAL
BENZACLIN
>A> @ SANOFI AVENTIS US 5%;EQ 1% BASE N50756 002 Apr 20, 2007 Apr DISC
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL
BENZPHETAMINE HYDROCHLORIDE
>A> AA TYCO HLTHCARE 50MG N40773 001 Apr 25, 2007 Apr NEWA
BETAINE HYDROCHLORIDE
FOR SOLUTION; ORAL
CYSTADANE
>D> + JAZZ 1GM/SCOOPFUL N20576 001 Oct 25, 1996 Apr CAHN
>A> + RARE DIS 1GM/SCOOPFUL N20576 001 Oct 25, 1996 Apr CAHN
CARBIDOPA; ENTACAPONE; LEVODOPA
TABLET; ORAL
STALEVO 50
>D> ORION PHARMA INC 12.5MG;200MG;50MG N21485 001 Jun 11, 2003 Apr CRLD
>A> + 12.5MG;200MG;50MG N21485 001 Jun 11, 2003 Apr CRLD
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP GENERAMEDIX EQ 50MG/5ML (10MG/ML) N77998 001 Apr 24, 2007 Apr NEWA
>A> AP EQ 150MG/ML (10MG/ML) N77998 002 Apr 24, 2007 Apr NEWA
>A> AP EQ 450MG/45ML (10MG/ML) N77998 003 Apr 24, 2007 Apr NEWA
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>D> AB CEPH INTL EQ 250MG BASE N62205 001 Apr DISC
>A> @ EQ 250MG BASE N62205 001 Apr DISC
>D> AB EQ 500MG BASE N62205 002 Apr DISC
>A> @ EQ 500MG BASE N62205 002 Apr DISC
CEFDINIR
FOR SUSPENSION; ORAL
CEFDINIR
>A> AB LUPIN 250MG/5ML N65259 002 May 07, 2007 Apr NEWA
>A> AB TEVA PHARMS 125MG/5ML N65332 001 May 04, 2007 Apr NEWA
>A> AB 250MG/5ML N65332 002 May 04, 2007 Apr NEWA
CEFIXIME
SUSPENSION; ORAL
CEFIXIME
>D> LUPIN PHARMS 200MG/5ML N65355 001 Apr 10, 2007 Apr CRLD
SUPRAX
>D> + LUPIN 100MG/5ML N65129 001 Feb 23, 2004 Apr CRLD
>A> LUPIN PHARMS 100MG/5ML N65129 001 Feb 23, 2004 Apr CRLD
>A> + 200MG/5ML N65355 001 Apr 10, 2007 Apr CRLD
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV
>A> CEFTRIAXONE
>A> AP TEVA EQ 1GM BASE/VIAL N65262 001 Jun 29, 2006 Apr CTNA
>A> AP EQ 2GM BASE/VIAL N65262 002 Jun 29, 2006 Apr CTNA
>A> AP WOCKHARDT EQ 250MG BASE/VIAL N65391 001 Apr 12, 2007 Apr NEWA
>A> AP EQ 500MG BASE/VIAL N65391 002 Apr 12, 2007 Apr NEWA
>A> AP EQ 2GM BASE/VIAL N65391 003 Apr 12, 2007 Apr NEWA
>D> CEFTRIAXONE SODIUM
>D> AP TEVA EQ 1GM BASE/VIAL N65262 001 Jun 29, 2006 Apr CTNA
>D> AP EQ 2GM BASE/VIAL N65262 002 Jun 29, 2006 Apr CTNA
CIPROFLOXACIN HYDROCHLORIDE
TABLET; ORAL
CIPROFLOXACIN
>A> AB AUROBINDO EQ 250MG BASE N77859 001 Apr 26, 2007 Apr NEWA
>A> AB EQ 500MG BASE N77859 002 Apr 26, 2007 Apr NEWA
>A> AB EQ 750MG BASE N77859 003 Apr 26, 2007 Apr NEWA
CORTISONE ACETATE
INJECTABLE; INJECTION
CORTISONE ACETATE
>D> @ PHARMACIA AND 25MG/ML N08126 002 Apr DISC
>A> @ 25MG/ML N08126 002 Apr DISC
TABLET; ORAL
CORTISONE ACETATE
>D> PHARMACIA AND 5MG N08126 003 Apr DISC
>A> @ 5MG N08126 003 Apr DISC
>D> 10MG N08126 004 Apr DISC
>A> @ 10MG N08126 004 Apr DISC
>D> BP + 25MG N08126 001 Apr DISC
>A> @ 25MG N08126 001 Apr DISC
>D> BP WEST WARD 25MG N80776 002 Apr CRLD
>A> + 25MG N80776 002 Apr CRLD
DANAZOL
CAPSULE; ORAL
DANAZOL
>D> BARR 50MG N74582 003 May 29, 1998 Apr CTEC
>A> AB 50MG N74582 003 May 29, 1998 Apr CTEC
>D> 100MG N74582 002 May 29, 1998 Apr CTEC
>A> AB 100MG N74582 002 May 29, 1998 Apr CTEC
>A> AB LANNETT 50MG N78214 001 Apr 19, 2007 Apr NEWA
>A> AB 100MG N78214 002 Apr 19, 2007 Apr NEWA
DESMOPRESSIN ACETATE
SPRAY, METERED; NASAL
STIMATE
>A> + CSL BEHRING 0.15MG/SPRAY N20355 001 Mar 07, 1994 Apr CAHN
>D> + ZLB BEHRING 0.15MG/SPRAY N20355 001 Mar 07, 1994 Apr CAHN
DOXORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
DOXORUBICIN HYDROCHLORIDE
>D> AP BEDFORD 10MG/VIAL N62921 001 Mar 17, 1989 Apr CRLD
>A> AP + 10MG/VIAL N62921 001 Mar 17, 1989 Apr CRLD
>D> AP 20MG/VIAL N62921 002 Mar 17, 1989 Apr CRLD
>A> AP + 20MG/VIAL N62921 002 Mar 17, 1989 Apr CRLD
>D> AP 50MG/VIAL N62921 003 Mar 17, 1989 Apr CRLD
>A> AP + 50MG/VIAL N62921 003 Mar 17, 1989 Apr CRLD
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
ELLENCE
>D> + PFIZER INC 2MG/ML N50778 001 Sep 15, 1999 Apr CFTG
>A> AP + 2MG/ML (200MG/100ML) N50778 001 Sep 15, 1999 Apr CFTG
>A> AP 2MG/ML (50MG/25ML) N50778 002 Sep 15, 1999 Apr CFTG
EPIRUBICIN HYDROCHLORIDE
>A> HOSPIRA 2MG/ML (10MG/5ML) N65343 001 Apr 19, 2007 Apr NEWA
>A> AP 2MG/ML (50MG/25ML) N65343 002 Apr 19, 2007 Apr NEWA
>A> 2MG/ML (150MG/75ML) N65343 003 Apr 19, 2007 Apr NEWA
>A> AP 2MG/ML (200MG/100ML) N65343 004 Apr 19, 2007 Apr NEWA
ESTAZOLAM
TABLET; ORAL
>D> PROSOM
>D> AB ABBOTT 1MG N19080 001 Dec 26, 1990 Apr DISC
>A> @ 1MG N19080 001 Dec 26, 1990 Apr DISC
>D> AB + 2MG N19080 002 Dec 26, 1990 Apr DISC
>A> @ 2MG N19080 002 Dec 26, 1990 Apr DISC
ESTROGENS, CONJUGATED SYNTHETIC B
TABLET; ORAL
ENJUVIA
>A> DURAMED 0.9MG N21443 005 Apr 27, 2007 Apr NEWA
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-28
LEVONORGESTREL AND ETHINYL ESTRADIOL
>D> AB1 WATSON LABS 0.02MG;0.1MG N76625 001 Nov 18, 2004 Apr CRLD
>A> AB1 + 0.02MG;0.1MG N76625 001 Nov 18, 2004 Apr CRLD
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
TABLET; ORAL-28
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
>D> AB ANDRX PHARMS 0.02MG;1MG N77077 001 May 20, 2005 Apr CAHN
>D> AB 0.03MG;1.5MG N77075 001 Apr 28, 2005 Apr CAHN
>A> AB TEVA PHARMS 0.02MG;1MG N77077 001 May 20, 2005 Apr CAHN
>A> AB 0.03MG;1.5MG N77075 001 Apr 28, 2005 Apr CAHN
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET; ORAL-28
PREVIFEM
>D> AB ANDRX PHARMS 0.035MG;0.25MG N76334 001 Jan 09, 2004 Apr CAHN
>A> AB TEVA PHARMS 0.035MG;0.25MG N76334 001 Jan 09, 2004 Apr CAHN
TRI-PREVIFEM
>D> AB ANDRX PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>D> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>D> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB TEVA PHARMS 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
>A> AB 0.035MG,0.035MG,0.035MG;0.18MG,0. N76335 001 Mar 26, 2004 Apr CAHN
ETODOLAC
CAPSULE; ORAL
ETODOLAC
>D> AB AAIPHARMA LLC 300MG N74929 001 Jan 30, 1998 Apr DISC
>A> @ 300MG N74929 001 Jan 30, 1998 Apr DISC
>D> AB GENPHARM 200MG N75071 001 Sep 30, 1998 Apr DISC
>A> @ 200MG N75071 001 Sep 30, 1998 Apr DISC
>D> AB 300MG N75071 002 Sep 30, 1998 Apr DISC
>A> @ 300MG N75071 002 Sep 30, 1998 Apr DISC
>D> AB MYLAN 200MG N74932 001 May 16, 1997 Apr DISC
>A> @ 200MG N74932 001 May 16, 1997 Apr DISC
>D> AB 300MG N74932 002 May 16, 1997 Apr DISC
>A> @ 300MG N74932 002 May 16, 1997 Apr DISC
>D> AB SANDOZ 200MG N74942 001 Sep 30, 1997 Apr DISC
>A> @ 200MG N74942 001 Sep 30, 1997 Apr DISC
>D> AB 200MG N74840 001 Aug 29, 1997 Apr DISC
>A> @ 200MG N74840 001 Aug 29, 1997 Apr DISC
>D> AB 300MG N74942 002 Sep 30, 1997 Apr DISC
>A> @ 300MG N74942 002 Sep 30, 1997 Apr DISC
>D> AB 300MG N74840 002 Aug 29, 1997 Apr DISC
>A> @ 300MG N74840 002 Aug 29, 1997 Apr DISC
>D> AB TEVA 200MG N75126 001 Sep 16, 1999 Apr DISC
>A> @ 200MG N75126 001 Sep 16, 1999 Apr DISC
>D> AB WATSON LABS 200MG N74844 001 Dec 23, 1997 Apr DISC
>A> @ 200MG N74844 001 Dec 23, 1997 Apr DISC
>D> AB 300MG N74844 002 Dec 23, 1997 Apr DISC
>A> @ 300MG N74844 002 Dec 23, 1997 Apr DISC
TABLET, EXTENDED RELEASE; ORAL
ETODOLAC
>D> AB ANDRX PHARMS 400MG N75829 001 Nov 30, 2001 Apr DISC
>A> @ 400MG N75829 001 Nov 30, 2001 Apr DISC
>D> AB 500MG N75829 002 Nov 30, 2001 Apr DISC
>A> @ 500MG N75829 002 Nov 30, 2001 Apr DISC
>D> AB SANDOZ 400MG N75943 001 Jul 26, 2002 Apr DISC
>A> @ 400MG N75943 001 Jul 26, 2002 Apr DISC
>D> AB 500MG N75943 002 Jul 26, 2002 Apr DISC
>A> @ 500MG N75943 002 Jul 26, 2002 Apr DISC
>D> AB 600MG N75943 003 Jul 26, 2002 Apr DISC
>A> @ 600MG N75943 003 Jul 26, 2002 Apr DISC
TABLET; ORAL
ETODOLAC
>D> AB AAIPHARMA LLC 400MG N74927 001 Oct 30, 1997 Apr DISC
>A> @ 400MG N74927 001 Oct 30, 1997 Apr DISC
>D> AB GENPHARM 400MG N75012 001 Sep 30, 1998 Apr DISC
>A> @ 400MG N75012 001 Sep 30, 1998 Apr DISC
>D> AB 500MG N75012 002 Sep 30, 1998 Apr DISC
>A> @ 500MG N75012 002 Sep 30, 1998 Apr DISC
>D> AB IVAX PHARMS 400MG N74883 001 Feb 28, 1997 Apr DISC
>A> @ 400MG N74883 001 Feb 28, 1997 Apr DISC
>D> AB 500MG N74883 002 Nov 20, 1998 Apr DISC
>A> @ 500MG N74883 002 Nov 20, 1998 Apr DISC
>D> AB RANBAXY 400MG N75226 001 Nov 24, 1998 Apr DISC
>A> @ 400MG N75226 001 Nov 24, 1998 Apr DISC
>D> AB 500MG N75226 002 Nov 24, 1998 Apr DISC
>A> @ 500MG N75226 002 Nov 24, 1998 Apr DISC
>D> AB SANDOZ 400MG N74846 001 Feb 28, 1997 Apr DISC
>A> @ 400MG N74846 001 Feb 28, 1997 Apr DISC
>D> AB 400MG N74839 001 Jul 11, 1997 Apr DISC
>A> @ 400MG N74839 001 Jul 11, 1997 Apr DISC
>D> AB TEVA 400MG N74847 001 Apr 23, 1999 Apr DISC
>A> @ 400MG N74847 001 Apr 23, 1999 Apr DISC
>D> AB 500MG N74847 002 Apr 23, 1999 Apr DISC
>A> @ 500MG N74847 002 Apr 23, 1999 Apr DISC
>D> AB WATSON LABS 400MG N75069 001 Apr 16, 1998 Apr DISC
>A> @ 400MG N75069 001 Apr 16, 1998 Apr DISC
>D> AB 400MG N74892 001 Apr 16, 1997 Apr DISC
>A> @ 400MG N74892 001 Apr 16, 1997 Apr DISC
>D> AB 500MG N74892 002 Oct 29, 1998 Apr DISC
>A> @ 500MG N74892 002 Oct 29, 1998 Apr DISC
FEXOFENADINE HYDROCHLORIDE
TABLET; ORAL
FEXOFENADINE HYDROCHLORIDE
>A> AB MYLAN 180MG N77081 001 Apr 16, 2007 Apr NEWA
FLUOROURACIL
INJECTABLE; INJECTION
FLUOROURACIL
>D> AP + ABRAXIS PHARM 50MG/ML N40379 001 Nov 15, 2000 Apr DISC
>A> @ 50MG/ML N40379 001 Nov 15, 2000 Apr DISC
>D> AP + 50MG/ML N40291 001 Mar 24, 1999 Apr DISC
>A> @ 50MG/ML N40291 001 Mar 24, 1999 Apr DISC
>A> AP + 500MG/10ML (50MG/ML) N40279 002 Sep 30, 1998 Apr NEWA
>D> AP + 50MG/ML N40279 001 Sep 30, 1998 Apr CPOT
>A> AP + 1GM/20ML (50MG/ML) N40279 001 Sep 30, 1998 Apr CPOT
>D> AP + 50MG/ML N40278 001 Sep 30, 1998 Apr CPOT
>A> AP + 2.5GM/50ML (50MG/ML) N40278 001 Sep 30, 1998 Apr CPOT
>A> AP + 5GM/100ML (50MG/ML) N40278 002 Sep 30, 1998 Apr NEWA
>A> AP + GENERAMEDIX 500MG/10ML (50MG/ML) N40743 002 Apr 26, 2007 Apr NEWA
>A> AP + 1GM/20ML (50MG/ML) N40743 001 Apr 26, 2007 Apr NEWA
>A> AP + 2.5GM/50ML (50MG/ML) N40798 002 Apr 26, 2007 Apr NEWA
>A> AP + 5GM/100ML (50MG/ML) N40798 001 Apr 26, 2007 Apr NEWA
>D> AP + SICOR PHARMS 50MG/ML N40333 001 Jan 27, 2000 Apr CPOT
>A> AP + 500MG/10ML (50MG/ML) N40333 001 Jan 27, 2000 Apr CPOT
>D> AP + 50MG/ML N40334 001 Feb 25, 2000 Apr CPOT
>A> AP + 2.5GM/50ML (50MG/ML) N40334 001 Feb 25, 2000 Apr CPOT
>A> AP + 5GM/100ML (50MG/ML) N40334 002 Feb 25, 2000 Apr NEWA
>D> AP + VALEANT 50MG/ML N12209 001 Apr CPOT
>A> AP + 500MG/10ML (50MG/ML) N12209 001 Apr CPOT
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
CAPSULE; ORAL
SYMBYAX
>A> LILLY EQ 25MG BASE;EQ 3MG BASE N21520 001 Apr NEWA
FLURBIPROFEN
TABLET; ORAL
FLURBIPROFEN
>A> AB THERAGEN 100MG N74560 002 May 16, 1997 Apr CAHN
>D> AB WARNER CHILCOTT 100MG N74560 002 May 16, 1997 Apr CAHN
>A> FLUTICASONE FUROATE
>A> SPRAY, METERED; NASAL
>A> VERAMYST
>A> + GLAXOSMITHKLINE 0.0275MG/INH N22051 001 Apr 27, 2007 Apr NEWA
GLIPIZIDE; METFORMIN HYDROCHLORIDE
TABLET; ORAL
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
>A> AB MYLAN 2.5MG;250MG N78083 001 Apr 12, 2007 Apr NEWA
>A> AB 2.5MG;500MG N78083 002 Apr 12, 2007 Apr NEWA
>A> AB 5MG;500MG N78083 003 Apr 12, 2007 Apr NEWA
HALOBETASOL PROPIONATE
CREAM; TOPICAL
HALOBETASOL PROPIONATE
>A> AB G AND W LABS 0.05% N78162 001 Apr 24, 2007 Apr NEWA
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
VANTAS
>A> + INDEVUS 50MG N21732 001 Oct 12, 2004 Apr CAHN
>D> + VALERA 50MG N21732 001 Oct 12, 2004 Apr CAHN
HYDROCODONE BITARTRATE; IBUPROFEN
TABLET; ORAL
HYDROCODONE BITARTRATE AND IBUPROFEN
>D> AB + INTERPHARM 5MG;200MG N76642 002 Mar 18, 2004 Apr CRLD
>A> AB 5MG;200MG N76642 002 Mar 18, 2004 Apr CRLD
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROMORPHONE HYDROCHLORIDE
>A> AP BARR 10MG/ML N76444 001 Apr 25, 2003 Apr CAHN
>D> AP MAYNE PHARMA 10MG/ML N76444 001 Apr 25, 2003 Apr CAHN
LAPATINIB DITOSYLATE
TABLET; ORAL
TYKERB
>D> + GLAXOSMITHKLINE EQ 250MG BASE N22059 001 Mar 13, 2007 Apr CAHN
>A> + SMITHKLINE EQ 250MG BASE N22059 001 Mar 13, 2007 Apr CAHN
LIDOCAINE; TETRACAINE
CREAM; TOPICAL
LIDOCAINE AND TETRACAINE
>A> + GALDERMA LABS LP 7%;7% N21717 001 Jun 29, 2006 Apr CAHN
>D> + ZARS 7%;7% N21717 001 Jun 29, 2006 Apr CAHN
LIOTHYRONINE SODIUM
INJECTABLE; INJECTION
TRIOSTAT
>D> AP + JONES PHARMA EQ 0.01MG BASE/ML N20105 001 Dec 31, 1991 Apr CAHN
>A> AP + KING PHARMS EQ 0.01MG BASE/ML N20105 001 Dec 31, 1991 Apr CAHN
LISINOPRIL
TABLET; ORAL
LISINOPRIL
>A> AB WOCKHARDT 2.5MG N78402 001 Apr 19, 2007 Apr NEWA
>A> AB 5MG N78402 002 Apr 19, 2007 Apr NEWA
>A> AB 10MG N78402 003 Apr 19, 2007 Apr NEWA
>A> AB 20MG N78402 004 Apr 19, 2007 Apr NEWA
>A> AB 30MG N78402 005 Apr 19, 2007 Apr NEWA
>A> AB 40MG N78402 006 Apr 19, 2007 Apr NEWA
METHOTREXATE SODIUM
INJECTABLE; INJECTION
>D> METHOTREXATE
>D> AP + ABRAXIS PHARM EQ 50MG BASE/2ML (25MG/ML) N40263 001 Feb 26, 1999 Apr CTNA
>D> AP + EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Apr CTNA
>D> AP + MAYNE PHARMA EQ 50MG BASE/2ML (25 MG/ML) N11719 010 Dec 15, 2004 Apr CTNA
METHOTREXATE LPF
>A> @ HOSPIRA EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr CAHN
>D> @ MAYNE PHARMA EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr CAHN
METHOTREXATE PRESERVATIVE FREE
>A> @ HOSPIRA EQ 20MG BASE/2ML (10 MG/ML) N11719 014 Apr 13, 2005 Apr CAHN
>A> @ EQ 500MG BASE/20ML (25 MG/ML) N11719 013 Apr 13, 2005 Apr CAHN
>A> @ EQ 2.5GM BASE/100ML (25 MG/ML) N11719 011 Apr 13, 2005 Apr CAHN
>D> @ MAYNE PHARMA EQ 20MG BASE/2ML (10 MG/ML) N11719 014 Apr 13, 2005 Apr CAHN
>D> @ EQ 500MG BASE/20ML (25 MG/ML) N11719 013 Apr 13, 2005 Apr CAHN
>D> + EQ 1GM BASE/40ML (25MG/ML) N11719 012 Apr 13, 2005 Apr CAHN
>D> @ EQ 2.5GM BASE/100ML (25 MG/ML) N11719 011 Apr 13, 2005 Apr CAHN
>A> METHOTREXATE SODIUM
>A> AP + ABRAXIS PHARM EQ 50MG BASE/2ML (25MG/ML) N40263 001 Feb 26, 1999 Apr CTNA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Apr CTNA
>D> AP + BEDFORD EQ 50MG BASE/2ML (25MG/ML) N89340 001 Sep 16, 1986 Apr CTNA
>D> + EQ 250MG BASE/10ML (25 MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
>A> @ HOSPIRA EQ 2.5MG BASE/ML N11719 004 Apr CAHN
>A> @ EQ 20MG BASE/VIAL N11719 001 Apr CAHN
>A> @ EQ 25MG BASE/ML N11719 005 Apr CAHN
>A> @ EQ 50MG BASE/VIAL N11719 003 Apr CAHN
>A> AP + EQ 50MG BASE/2ML (25 MG/ML) N11719 010 Dec 15, 2004 Apr CTNA
>A> @ EQ 100MG BASE/VIAL N11719 006 Apr CAHN
>D> @ MAYNE PHARMA EQ 2.5MG BASE/ML N11719 004 Apr CAHN
>D> @ EQ 20MG BASE/VIAL N11719 001 Apr CAHN
>D> @ EQ 25MG BASE/ML N11719 005 Apr CAHN
>D> @ EQ 50MG BASE/VIAL N11719 003 Apr CAHN
>D> @ EQ 100MG BASE/VIAL N11719 006 Apr CAHN
>A> METHOTREXATE SODIUM PRESERVATIVE FREE
>A> AP + BEDFORD EQ 50MG BASE/2ML (25MG/ML) N89340 001 Sep 16, 1986 Apr CTNA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
>A> AP + GENERAMEDIX EQ 50MG BASE/2ML (25MG/ML) N40767 001 Apr 30, 2007 Apr NEWA
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N40768 001 Apr 30, 2007 Apr NEWA
>A> AP + EQ 1GM BASE/40ML (25MG/ML) N40716 001 Apr 30, 2007 Apr NEWA
>A> @ HOSPIRA EQ 1GM BASE/VIAL N11719 009 Apr 07, 1988 Apr CAHN
>A> AP + EQ 1GM BASE/40ML (25MG/ML) N11719 012 Apr 13, 2005 Apr CAHN
>D> @ MAYNE PHARMA EQ 1GM BASE/VIAL N11719 009 Apr 07, 1988 Apr CAHN
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CONCERTA
>A> ALZA 18MG N21121 001 Aug 01, 2000 Apr CAHN
>A> 27MG N21121 004 Apr 01, 2002 Apr CAHN
>A> 36MG N21121 002 Aug 01, 2000 Apr CAHN
>A> + 54MG N21121 003 Dec 08, 2000 Apr CAHN
>D> JOHNSON AND 18MG N21121 001 Aug 01, 2000 Apr CAHN
>D> 27MG N21121 004 Apr 01, 2002 Apr CAHN
>D> 36MG N21121 002 Aug 01, 2000 Apr CAHN
>D> + 54MG N21121 003 Dec 08, 2000 Apr CAHN
MEXILETINE HYDROCHLORIDE
CAPSULE; ORAL
MEXILETINE HYDROCHLORIDE
>D> AB TEVA 250MG N74377 003 May 16, 1995 Apr CRLD
>A> AB + 250MG N74377 003 May 16, 1995 Apr CRLD
>D> MEXITIL
>D> AB BOEHRINGER 150MG N18873 002 Dec 30, 1985 Apr DISC
>A> @ 150MG N18873 002 Dec 30, 1985 Apr DISC
>D> AB 200MG N18873 003 Dec 30, 1985 Apr DISC
>A> @ 200MG N18873 003 Dec 30, 1985 Apr DISC
>D> AB + 250MG N18873 004 Dec 30, 1985 Apr DISC
>A> @ 250MG N18873 004 Dec 30, 1985 Apr DISC
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HYDROCHLORIDE
>D> AP HOSPIRA EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Apr CRLD
>A> AP + EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Apr CRLD
MOMETASONE FUROATE
CREAM; TOPICAL
MOMETASONE FUROATE
>A> AB TOLMAR 0.1% N76591 001 Apr 18, 2007 Apr NEWA
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
KADIAN
>A> ALPHARMA BRANDED 10MG N20616 008 Apr 20, 2007 Apr NEWA
>A> 20MG N20616 001 Jul 03, 1996 Apr CAHN
>A> BX 30MG N20616 004 Mar 09, 2001 Apr CAHN
>A> 50MG N20616 002 Jul 03, 1996 Apr CAHN
>A> BX 60MG N20616 005 Mar 09, 2001 Apr CAHN
>A> 80MG N20616 006 Oct 27, 2006 Apr CAHN
>A> + 100MG N20616 003 Jul 03, 1996 Apr CAHN
>A> 200MG N20616 007 Feb 27, 2007 Apr CAHN
>D> ALPHARMA US 20MG N20616 001 Jul 03, 1996 Apr CAHN
>D> BX 30MG N20616 004 Mar 09, 2001 Apr CAHN
>D> 50MG N20616 002 Jul 03, 1996 Apr CAHN
>D> BX 60MG N20616 005 Mar 09, 2001 Apr CAHN
>D> 80MG N20616 006 Oct 27, 2006 Apr CAHN
>D> + 100MG N20616 003 Jul 03, 1996 Apr CAHN
>D> 200MG N20616 007 Feb 27, 2007 Apr CAHN
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
NALBUPHINE HYDROCHLORIDE
>A> AP BARR 10MG/ML N74471 001 Mar 19, 1998 Apr CAHN
>A> AP 20MG/ML N74471 002 Mar 19, 1998 Apr CAHN
>D> AP MAYNE PHARMA 10MG/ML N74471 001 Mar 19, 1998 Apr CAHN
>D> AP 20MG/ML N74471 002 Mar 19, 1998 Apr CAHN
NAPROXEN SODIUM
TABLET; ORAL
NAPROXEN SODIUM
>A> AB GLENMARK EQ 250MG BASE N78314 001 Apr 27, 2007 Apr NEWA
>A> AB EQ 500MG BASE N78314 002 Apr 27, 2007 Apr NEWA
>A> AB INTERPHARM EQ 250MG BASE N78432 001 Apr 25, 2007 Apr NEWA
>A> AB EQ 500MG BASE N78432 002 Apr 25, 2007 Apr NEWA
NEOMYCIN SULFATE
TABLET; ORAL
NEOMYCIN SULFATE
>D> AB + TEVA 500MG N60304 001 Apr CTEC
>A> AA + 500MG N60304 001 Apr CTEC
>D> AB X GEN PHARMS 500MG N65220 001 Jul 28, 2006 Apr CTEC
>A> AA 500MG N65220 001 Jul 28, 2006 Apr CTEC
NIACIN
TABLET, EXTENDED RELEASE; ORAL
NIASPAN
>D> + ABBOTT 500MG N20381 002 Jul 28, 1997 Apr CRLD
>A> 500MG N20381 002 Jul 28, 1997 Apr CRLD
NIMODIPINE
CAPSULE; ORAL
NIMODIPINE
>A> AB BARR 30MG N77811 001 May 02, 2007 Apr NEWA
>A> AB SUN PHARM INDS 30MG N77067 001 Apr 17, 2007 Apr NEWA
NIMOTOP
>D> + BAYER PHARMS 30MG N18869 001 Dec 28, 1988 Apr CFTG
>A> AB + 30MG N18869 001 Dec 28, 1988 Apr CFTG
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVACHOL
>D> + BRISTOL MYERS 80MG N19898 008 Dec 18, 2001 Apr CFTG
>A> AB + 80MG N19898 008 Dec 18, 2001 Apr CFTG
PRAVASTATIN SODIUM
>A> AB RANBAXY 10MG N76445 001 Apr 23, 2007 Apr NEWA
>A> AB 20MG N76445 002 Apr 23, 2007 Apr NEWA
>A> AB 40MG N76445 003 Apr 23, 2007 Apr NEWA
>A> AB 80MG N76445 004 Apr 23, 2007 Apr NEWA
PROMETHAZINE HYDROCHLORIDE
TABLET; ORAL
PROMETHAZINE HYDROCHLORIDE
>A> AB KVK-TECH INC 12.5MG N40712 002 May 04, 2007 Apr NEWA
QUINIDINE SULFATE
TABLET; ORAL
QUINIDINE SULFATE
>D> AB WATSON LABS 300MG N85583 001 Apr DISC
>A> @ 300MG N85583 001 Apr DISC
RAMIPRIL
TABLET; ORAL
ALTACE
>D> COBALT 1.25MG N22021 001 Feb 27, 2007 Apr CAHN
>D> 2.5MG N22021 002 Feb 27, 2007 Apr CAHN
>D> 5MG N22021 003 Feb 27, 2007 Apr CAHN
>D> + 10MG N22021 004 Feb 27, 2007 Apr CAHN
>A> KING PHARMS 1.25MG N22021 001 Feb 27, 2007 Apr CAHN
>A> 2.5MG N22021 002 Feb 27, 2007 Apr CAHN
>A> 5MG N22021 003 Feb 27, 2007 Apr CAHN
>A> + 10MG N22021 004 Feb 27, 2007 Apr CAHN
>A> RETAPAMULIN
>A> OINTMENT; TOPICAL
>A> ALTABAX
>A> + GLAXO GRP LTD 1% N22055 001 Apr 12, 2007 Apr NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>A> + PROCTER AND 75MG N20835 004 Apr 16, 2007 Apr NEWA
RISPERIDONE
INJECTABLE; INTRAMUSCULAR
RISPERDAL CONSTA
>A> JANSSEN PHARMA 12.5MG/VIAL N21346 004 Apr 12, 2007 Apr NEWA
SERTRALINE HYDROCHLORIDE
TABLET; ORAL
SERTRALINE HYDROCHLORIDE
>A> AB DR REDDYS LABS EQ 25MG BASE N76442 001 Apr 30, 2007 Apr NEWA
>A> AB EQ 50MG BASE N76442 002 Apr 30, 2007 Apr NEWA
>A> AB EQ 100MG BASE N76442 003 Apr 30, 2007 Apr NEWA
SEVOFLURANE
LIQUID; INHALATION
>A> SOJOURN
>A> AN MINRAD 100% N77867 001 May 02, 2007 Apr NEWA
SODIUM CHLORIDE
INJECTABLE; INJECTION
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A> AP FRESENIUS MEDCL 900MG/100ML N78177 001 Apr 12, 2007 Apr NEWA
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
>A> VALTROPIN
>A> BX LG LIFE 5MG/VIAL N21905 001 Apr 19, 2007 Apr NEWA
SULFANILAMIDE
CREAM; VAGINAL
AVC
>A> + AZUR PHARMA 15% N06530 003 Jan 27, 1987 Apr CAHN
>D> + PHARMELLE 15% N06530 003 Jan 27, 1987 Apr CAHN
SUPPOSITORY; VAGINAL
AVC
>A> @ AZUR PHARMA 1.05GM N06530 004 Jan 27, 1987 Apr CAHN
>D> @ PHARMELLE 1.05GM N06530 004 Jan 27, 1987 Apr CAHN
TADALAFIL
TABLET; ORAL
CIALIS
>A> LILLY 5MG N21368 001 Nov 21, 2003 Apr CAHN
>A> 10MG N21368 002 Nov 21, 2003 Apr CAHN
>A> + 20MG N21368 003 Nov 21, 2003 Apr CAHN
>D> LILLY ICOS 5MG N21368 001 Nov 21, 2003 Apr CAHN
>D> 10MG N21368 002 Nov 21, 2003 Apr CAHN
>D> + 20MG N21368 003 Nov 21, 2003 Apr CAHN
TERBUTALINE SULFATE
TABLET; ORAL
>D> BRETHINE
>D> AB AAIPHARMA LLC 2.5MG N17849 001 Apr DISC
>A> @ 2.5MG N17849 001 Apr DISC
>D> AB + 5MG N17849 002 Apr DISC
>A> @ 5MG N17849 002 Apr DISC
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
ACHROMYCIN V
>A> @ HERITAGE PHARMS 250MG N50278 003 Apr CAHN
>A> @ 500MG N50278 001 Apr CAHN
>D> @ RADIUS PHARMS 250MG N50278 003 Apr CAHN
>D> @ 500MG N50278 001 Apr CAHN
TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
ULTRAM ER
>D> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Apr CRLD
>A> + 100MG N21692 001 Sep 08, 2005 Apr CRLD
>D> + 300MG N21692 003 Sep 08, 2005 Apr CRLD
>A> 300MG N21692 003 Sep 08, 2005 Apr CRLD
TRIAMCINOLONE ACETONIDE
CREAM; TOPICAL
TRIAMCINOLONE ACETONIDE
>D> AT ALTANA 0.5% N85692 002 Apr CRLD
>A> AT + 0.5% N85692 002 Apr CRLD
VALRUBICIN
SOLUTION; INTRAVESICAL
VALSTAR PRESERVATIVE FREE
>A> + INDEVUS PHARMS 40MG/ML N20892 001 Sep 25, 1998 Apr CAHN
>D> + VALERA 40MG/ML N20892 001 Sep 25, 1998 Apr CAHN
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION)
>A> RECLAST
>A> + NOVARTIS EQ 5MG BASE/100ML N21817 001 Apr 16, 2007 Apr NEWA
ZOLPIDEM TARTRATE
>A> TABLET, ORALLY DISINTEGRATING; ORAL
>A> TOVALT ODT
>A> BIOVAIL LABS INTL 5MG N21412 001 Apr 25, 2007 Apr NEWA
>A> + 10MG N21412 002 Apr 25, 2007 Apr NEWA
TABLET; ORAL
AMBIEN
>D> SANOFI AVENTIS US 5MG N19908 001 Dec 16, 1992 Apr CFTG
>A> AB 5MG N19908 001 Dec 16, 1992 Apr CFTG
>D> + 10MG N19908 002 Dec 16, 1992 Apr CFTG
>A> AB + 10MG N19908 002 Dec 16, 1992 Apr CFTG
>A> ZOLPIDEM TARTRATE
>A> AB APOTEX INC 5MG N77884 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77884 002 Apr 23, 2007 Apr NEWA
>A> AB AUROBINDO 5MG N78413 001 May 04, 2007 Apr NEWA
>A> AB 10MG N78413 002 May 04, 2007 Apr NEWA
>A> AB CARACO 5MG N77359 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77359 002 Apr 23, 2007 Apr NEWA
>A> AB CARLSBAD 5MG N77990 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77990 002 Apr 23, 2007 Apr NEWA
>A> AB DR REDDYS LABS 5MG N77985 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77985 002 Apr 23, 2007 Apr NEWA
>A> AB GENPHARM 5MG N78016 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N78016 002 Apr 23, 2007 Apr NEWA
>A> AB LEK PHARMS DD 5MG N77322 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77322 002 Apr 23, 2007 Apr NEWA
>A> AB MUTUAL PHARMA 5MG N77288 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77288 002 Apr 23, 2007 Apr NEWA
>A> AB MYLAN 5MG N76578 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76578 002 Apr 23, 2007 Apr NEWA
>A> AB PAR PHARM 5MG N76062 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76062 002 Apr 23, 2007 Apr NEWA
>A> AB RANBAXY 5MG N78055 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N78055 002 Apr 23, 2007 Apr NEWA
>A> AB ROXANE 5MG N77214 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77214 002 Apr 23, 2007 Apr NEWA
>A> AB SYNTHON PHARMS 5MG N77540 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77540 002 Apr 23, 2007 Apr NEWA
>A> AB TEVA 5MG N76410 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N76410 002 Apr 23, 2007 Apr NEWA
>A> AB WATSON LABS 5MG N77773 001 Apr 23, 2007 Apr NEWA
>A> AB 10MG N77773 002 Apr 23, 2007 Apr NEWA
>A> DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
>A> CAPSULE; ORAL
>A> ADVIL PM
>A> + WYETH CONS 25MG;EQ 200MG FREE ACID AND N21393 001 Dec 21, 2005 Apr CAIN
>D> DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN POTASSIUM
>D> CAPSULE; ORAL
>D> ADVIL PM
>D> + WYETH CONS 25MG;200MG N21393 001 Dec 21, 2005 Apr CAIN
GUAIFENESIN
TABLET, EXTENDED RELEASE; ORAL
>D> HUMABID
>D> + ADAMS RESP 1.2GM N21282 002 Dec 18, 2002 Apr CTNA
>A> HUMIBID
>A> + ADAMS RESP 1.2GM N21282 002 Dec 18, 2002 Apr CTNA
>D> IBUPROFEN POTASSIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
>D> CAPSULE; ORAL
>D> ADVIL COLD AND SINUS
>D> + WYETH CONS 200MG;30MG N21374 001 May 30, 2002 Apr CAIN
>A> IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
>A> CAPSULE; ORAL
>A> ADVIL COLD AND SINUS
>A> + WYETH CONS EQ 200MG FREE ACID AND N21374 001 May 30, 2002 Apr CAIN
LORATADINE
TABLET, ORALLY DISINTEGRATING; ORAL
>A> LORATADINE REDIDOSE
>A> RANBAXY 10MG N77153 001 Apr 11, 2007 Apr NEWA
Back
to Top
Back to Additions/Deletions Index
Date created: May 9, 2007; updated August 8, 2007 |
![](https://webarchive.library.unt.edu/eot2008/20081005104919im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |